Published in Surgery on July 01, 1996
In vitro reconstructed tissues on hyaluronan-based temporary scaffolding. J Mater Sci Mater Med (2004) 0.87
Burns (Part 2). Tops and flops using cultured epithelial autografts in children. Pediatr Surg Int (1997) 0.84
An in vitro examination of an extracellular matrix scaffold for use in wound healing. Int J Exp Pathol (2002) 0.83
Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds. Healthcare (Basel) (2014) 0.75
Tissue engineering in burn scar reconstruction. Burns Trauma (2015) 0.75
Cardiopulmonary resuscitation by medical and surgical house-officers. Lancet (1981) 6.33
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Video recording trauma resuscitations: an effective teaching technique. J Trauma (1988) 2.44
Mutants of Saccharomyces cerevisiae resistant to the alpha mating-type factor. Genetics (1976) 2.29
Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 2.06
The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma (1991) 1.64
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Prospective, randomized trial of hypertonic sodium lactate versus lactated Ringer's solution for burn shock resuscitation. J Trauma (1989) 1.47
Influence of head and neck position on endotracheal tube tip position on chest x-ray examination: a potential problem in the infant undergoing intubation. J Burn Care Rehabil (1995) 1.39
Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev (1997) 1.39
Treatment of burned mice with hyperbaric oxygen reduces mesenteric bacteria but not pulmonary neutrophil deposition. Arch Surg (1994) 1.38
Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res (2000) 1.37
Elevated radioxenon detected remotely following the Fukushima nuclear accident. J Environ Radioact (2011) 1.25
The capacity of bifunctional antigens to bridge antibody molecules and to mediate cell cooperation. Immunochemistry (1975) 1.23
Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds. J Trauma (1987) 1.11
Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J Clin Microbiol (2008) 1.10
Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery (1988) 1.08
Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res (1988) 1.08
Comparison of Biobrane and Scarlet Red dressings for treatment of donor site wounds. Arch Surg (1985) 1.02
Use of overhead hooks in burn surgery. J Burn Care Rehabil (1989) 1.01
Reduction of bacterial translocation and intestinal structural alterations by heparin in a murine burn injury model. J Trauma (1994) 0.98
Placement of 10-gauge catheter by cutdown for rapid fluid replacement. J Trauma (1983) 0.97
Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int (1998) 0.97
Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am J Surg (1984) 0.95
Immunosuppression by hyperbaric oxygen. Surgery (1980) 0.95
A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil (1997) 0.94
Neutrophil activation and tissue neutrophil sequestration in a rat model of thermal injury. J Surg Res (1996) 0.94
Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch Dermatol Res (1997) 0.93
Postburn immunosuppression in an animal model: monocyte dysfunction induced by burned tissue. Surgery (1983) 0.93
Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons. Transplant Proc (1999) 0.92
Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors. Surgery (1991) 0.92
In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials (1991) 0.92
Current concepts in the development of cultured skin replacements. J Surg Res (1996) 0.91
Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res (1990) 0.91
Reconstitution of the histologic characteristics of a giant congenital nevomelanocytic nevus employing the athymic mouse and a cultured skin substitute. J Invest Dermatol (1991) 0.90
Clinical experience with Biobrane biosynthetic dressing in the treatment of partial thickness burns. Burns Incl Therm Inj (1984) 0.90
Safety and efficacy of TransCyte for the treatment of partial-thickness burns. J Burn Care Rehabil (1999) 0.89
Warfarin-induced skin necrosis: an entity occasionally requiring burn wound expertise. Burns Incl Therm Inj (1988) 0.89
Microbial contamination in allografted wound beds in patients with burns. J Burn Care Rehabil (1992) 0.88
Postburn immunosuppression in an animal model. III. Maintenance of normal splenic helper and suppressor lymphocyte subpopulations by immunomodulating drugs. Surgery (1985) 0.88
Thermoregulation in burn patients during exercise. J Burn Care Rehabil (2003) 0.87
Management of cutaneous manifestations of extensive purpura fulminans in a burn unit. J Burn Care Rehabil (1992) 0.87
Bacterial translocation in burned mice after administration of various diets including fiber- and glutamine-enriched enteral formulas. Crit Care Med (1994) 0.86
Postburn serum drug binding and serum protein concentrations. J Clin Pharmacol (1986) 0.86
Effect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions. Crit Care Med (1990) 0.86
Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med (1992) 0.86
Success of immediate intragastric feeding of patients with burns. J Burn Care Rehabil (1993) 0.85
Postburn immunosuppression in an animal model. IV. Improved resistance to septic challenge with immunomodulating drugs. Surgery (1986) 0.85
Immunomodulation following burn injury. Surg Clin North Am (1987) 0.84
Head injury: an immunologic deficit in T-cell activation. J Trauma (1990) 0.84
Immunomodulating drugs increase resistance against sepsis in traumatized mice. J Trauma (1986) 0.83
Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn wounds. J Trauma (1999) 0.83
Antibody formation after murine injury. J Surg Res (1988) 0.83
Enteral nutritional support and wound excision and closure do not prevent postburn hypermetabolism as measured by continuous metabolic monitoring. J Trauma (2000) 0.83
Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg (1986) 0.82
Granulocyte stem cells are decreased in humans with fatal burns. J Trauma (1985) 0.82
Spontaneous bacterial peritonitis and pneumoperitoneum. A false surgical emergency. JAMA (1983) 0.82
Development of a device for measuring adherence of skin grafts to the wound surface. Ann Biomed Eng (1993) 0.82
Management of skin-grafted burn wounds with Xeroform and layers of dry coarse-mesh gauze dressing results in excellent graft take and minimal nursing time. J Burn Care Rehabil (1996) 0.81
Hypersensitivity to Biobrane. Plast Reconstr Surg (1986) 0.81
Cyclosporine A for prolonging allograft survival in patients with massive burns. J Burn Care Rehabil (1991) 0.81
Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients. Am J Surg (1984) 0.81
Direct comparison of a cultured composite skin substitute containing human keratinocytes and fibroblasts to an epidermal sheet graft containing human keratinocytes on athymic mice. J Invest Dermatol (1993) 0.81
Current trends in the use of allograft skin for patients with burns and reflections on the future of skin banking in the United States. J Burn Care Rehabil (1995) 0.81
Biotinylation of implantable collagen for drug delivery. J Biomed Mater Res (1992) 0.80
In vitro differentiation of mouse embryonic yolk sac cells. Differentiation (1987) 0.80
A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients. J Burn Care Rehabil (2001) 0.80
Ultrastructural features of composite skin cultures grafted onto athymic mice. J Anat (1994) 0.80
Use of a composite skin graft composed of cultured human keratinocytes and fibroblasts and a collagen-GAG matrix to cover full-thickness wounds on athymic mice. Surgery (1991) 0.80
Immunosuppression with hyperbaric oxygen. Surg Forum (1979) 0.80
Arteriovenous fistulas following central venous catheterization. Intensive Care Med (1983) 0.80
Acellular human dermis promotes cultured keratinocyte engraftment. J Burn Care Rehabil (1998) 0.80
Effects of E-selectin and P-selectin blockade on neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit Care Med (1996) 0.80
Absence of tumorigenicity in athymic mice by normal human epidermal keratinocytes after culture in serum-free medium. Cancer Lett (1992) 0.79
Attachment of peptide growth factors to implantable collagen. J Surg Res (1989) 0.79
The effects of epidermal growth factor and basic fibroblast growth factor on epithelialization of meshed skin graft interstices. Prog Clin Biol Res (1991) 0.79
Supplementation of an elemental enteral diet with alanyl-glutamine decreases bacterial translocation in burned mice. Burns (1994) 0.79
Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care. J Burn Care Rehabil (1993) 0.79
Quantitation of cytokine levels in skin graft donor site wound fluid. Burns (1993) 0.79
Soft tissue infection prophylaxis with gentamicin encapsulated in multivesicular liposomes: results from a prospective, randomized trial. Crit Care Med (1995) 0.78
Cardiovascular and neurohumoral responses following burn injury. Arch Surg (1990) 0.78
Burn injury results in decreased gastric acid production in the acute shock period. J Burn Care Rehabil (1996) 0.78
Trauma peptide induction of lymphocyte changes predictive of sepsis. J Surg Res (1988) 0.78
Prevention of posttraumatic alterations in lymphocyte subpopulations in mice by immunomodulating drugs. Arch Surg (1986) 0.78
Pharmacokinetics of DepoFoam gentamicin delivery system and effect on soft tissue infection. J Surg Res (1993) 0.78
Temporal analysis of human leucocyte surface antigen expression and neutrophil respiratory burst activity after thermal injury. Burns (1993) 0.77
Characterization of the immunosuppressive effect of burned tissue in an animal model. J Surg Res (1984) 0.77
Reduced wound contraction after grafting of full-thickness burns with a collagen and chondroitin-6-sulfate (GAG) dermal skin substitute and coverage with biobrane. J Burn Care Rehabil (1989) 0.77
Effects of early and delayed wound excision on pulmonary leukosequestration and neutrophil respiratory burst activity in burned mice. Surgery (1995) 0.77
Cardiac perforation and tamponade from a malpositioned subclavian dialysis catheter. Nephron (1982) 0.77
Restoration of immunity in burned mice by cimetidine. J Trauma (1985) 0.77
Hydrocarbon contact injuries. J Trauma (1985) 0.77
The effect of an arginine-glycine-aspartic acid peptide and hyaluronate synthetic matrix on epithelialization of meshed skin graft interstices. J Burn Care Rehabil (1996) 0.76